Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;54(9):2181-2186.
doi: 10.1007/s11255-022-03251-z. Epub 2022 Jun 27.

Do no harm: the role of perioperative heparin in urethroplasty

Harry H Lee  1 , Nathan M Shaw  2 , Erin Hays  2 , Krishnan Venkatesan  3   4
Affiliations

Do no harm: the role of perioperative heparin in urethroplasty

Harry H Lee et al. Int Urol Nephrol. 2022 Sep.

Abstract

Objective: To examine the safety of single modality mechanical venous thromboembolism (VTE) prophylaxis in patients undergoing urethroplasty. VTE is a perioperative complication with significant morbidity. Routine use of peri-operative VTE prophylaxis is common guideline-driven practice across multiple surgical specialties. There is a discrepancy between guideline recommendations and clinical practice in the administration of peri-operative low-dose unfractionated heparin (LDUH) for urethroplasty.

Methods: Patients were identified from an IRB-approved database of patients undergoing urethral reconstruction by a single surgeon at MedStar Washington Hospital Center from 2012 to 2020. All patients had sequential compression devices (SCD) prior to anesthesia induction. Select patients received LDUH as dual prophylaxis. Primary endpoint was perioperative VTE within 30 days.

Results: We identified 345 patients who met inclusion criteria. Sixty-nine patients received peri-operative LDUH. One patient had a deep vein thrombosis in the SCD only group.

Conclusion: Routine LDUH administration likely overtreats men undergoing urethroplasty. There may be a subset of men in whom dual prophylaxis with LDUH and SCD is beneficial for prevention of VTE. Current guidelines do not offer adequate criteria to identify these men. We offer clinical considerations to help guide further study to identify these patients.

Keywords: Heparin; Perioperative care; Urethroplasty; VTE prophylaxis.

PubMed Disclaimer

References

    1. Smilowitz NR et al (2017) Trends in perioperative venous thromboembolism associated with major noncardiac surgery. TH Open 1(2):e82–e91 - DOI
    1. Gould MK et al (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2):e227S-e277S - DOI
    1. Caprini JA et al (1991) Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 17(Suppl 3):304–312 - PubMed
    1. Deitelzweig SB et al (2010) Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis? J Thromb Thrombolysis 30(1):55–66 - DOI
    1. Pannucci CJ et al (2017) Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg 265(6):1094–1103 - DOI

MeSH terms

LinkOut - more resources